Tian, Yuxi http://orcid.org/0000-0002-2126-7199
Reichardt, Berthold
Dunkler, Daniela http://orcid.org/0000-0003-1339-0311
Hronsky, Milan
Winkelmayer, Wolfgang C.
Bucsics, Anna http://orcid.org/0000-0002-5315-0497
Strohmaier, Susanne
Heinze, Georg http://orcid.org/0000-0003-1147-8491
Article History
Received: 4 October 2019
Accepted: 9 March 2020
First Online: 6 April 2020
Competing interests
: This study was conducted under contract number Zl.21-VPM-68.92/11 between the Medical University of Vienna (Georg Heinze, Principal Investigator) and the Main Association of Austrian Social Security Institutions. The study was financed by the Main Association of Austrian Social Security Institutions and the Austrian Agency for Health and Food Safety. We acknowledge the valuable technical support of the cosponsors, of the pharmacoeconomical advisory group of the Austrian social security institutions, and of the Österreichische Apotheker-Verlagsgesellschaft mbH. Susanne Strohmaier received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodwoska-Curie grant agreement No 795292. There were no contractual restrictions to publication. W. C. W. received personal fees for consultancy or for membership in advisory boards from Akebia, Amgen, AstraZeneca, Bayer, Daiichi-Sankyo, Relypsa and Vifer. None of the other authors report any financial conflicts of interest.